Bone Resorption
Assay
Click Here
To Download Sample Report
People at risk for rapid bone
loss: Men and women over 50
Perimenopausal and postmenopausal women Women recently pregnant or nursing Slender, small-framed
women Tobacco users Heavy alcohol consumers (particularly
men) Men and women with lactose intolerance or dairy
allergy Race, particularly Caucasian or southeast Asian
descent History of dieting
Conditions associated with
rapid bone loss: Sedentary
lifestyle Family history of osteoporosis Overactive thryroid Depression Selected
medications Hysterectomy Stress Low vitamin D and
calcium Weak digestion Irregular periods
Weak adrenals
Do You Know The Warning Signs Of
Osteoporosis?
Unfortunately, there are none...
Accelerated bone loss affects more than 44 million
Americans 50 years of age and older. 80% of them are women. But men, younger women and otherwise healthy, active
individuals can also experience the dangerous thinning and weakening of bones known as
osteoporosis.
Bone Density = Formation -
Resorption
Bone is a very active tissue undergoing constant "remodeling,"
a process of formation and resorption (breakdown). Osteoporosis, a loss of bone density,
occurs when the resorption rate is greater than the rate of formation of new bone.
Since bone formation is difficult to assess, it is important to identify if you are among the men and women with
rapid bone breakdown. If you are, you have the greatest risk for osteoporosis.
On a positive note, you are also among the group who can benefit most from therapies that your clinician might
recommend.
Fortunately, there is a test that can show if
you are at risk.
A series of bone scans can be expensive and can only indicate
changes in your bones over a six to twelve month period. They do not show your current bone activity.
The Bone Resorption Assay detects biochemical markers which reflect present remodeling activity. This test is
simple and cost-effective, allowing you to routinely monitor bone resorption rates and the effectiveness of
therapy.
Repeated measurements will allow your healthcare practitioner to monitor the effectiveness of your therapeutic
interventions so you can achieve the most
benefit in the shortest time.
Osteoporosis is a major public
threat for an estimated 44 million Americans.
In the US today, 10 million (8 million being
women and 2 million being men) individuals are estimated to already have the disease and
almost 34 million more are estimated to have
low bone mass, placing them at increased risk for osteoporosis." - National Osteoporosis Foundation
|